Nasdaq Impl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Impel Pharmaceuticals (NASDAQ:IMPL – Get Free Report) and Antibe Therapeutics (OTCMKTS:ATBPF – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, risk, valuation, profitability, dividends, analyst recommendations and institutional ownership. Valuation and Earnings This table compares Impel […]

Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Free Report) saw a significant drop in short interest in August. As of August 31st, there was short interest totalling 505,100 shares, a drop of 12.7% from the August 15th total of 578,800 shares. Currently, 6.5% of the company’s stock are short sold. Based on an average daily volume […]

Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating)’s stock price dropped 7.6% during trading on Monday . The company traded as low as $1.22 and last traded at $1.22. Approximately 20,793 shares changed hands during trading, a decline of 59% from the average daily volume of 50,243 shares. The stock had previously closed at $1.32. Impel […]

Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 424,400 shares, an increase of 8.9% from the April 15th total of 389,700 shares. Approximately 5.5% of the shares of the stock are short sold. Based on […]

Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 424,400 shares, an increase of 8.9% from the April 15th total of 389,700 shares. Based on an average trading volume of 46,600 shares, the days-to-cover ratio is […]